Literature DB >> 32118552

Methodologic Progress Note: Opportunistic Sampling for Pharmacology Studies in Hospitalized Children.

Sonya Tang Girdwood1,2, Jennifer Kaplan3,4, Alexander A Vinks2,4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 32118552      PMCID： PMC7768918          DOI： 10.12788/jhm.3380

Source DB:  PubMed          Journal:  J Hosp Med        ISSN： 1553-5592            Impact factor:   2.960


× No keyword cloud information.
  10 in total

1.  Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.

Authors:  Stéphanie Leroux; Mark A Turner; Chantal Barin-Le Guellec; Helen Hill; Johannes N van den Anker; Gregory L Kearns; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

2.  Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.

Authors:  Thomas J Hwang; Liat Orenstein; Aaron S Kesselheim; Florence T Bourgeois
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

Review 3.  Innovative clinical trial design for pediatric therapeutics.

Authors:  Matthew M Laughon; Daniel K Benjamin; Edmund V Capparelli; Gregory L Kearns; Katherine Berezny; Ian M Paul; Kelly Wade; Jeff Barrett; Phillip Brian Smith; Michael Cohen-Wolkowiez
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

4.  Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Authors:  Michael Rieder
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

5.  Pharmacokinetics of Clindamycin in Obese and Nonobese Children.

Authors:  Michael J Smith; Daniel Gonzalez; Jennifer L Goldman; Ram Yogev; Janice E Sullivan; Michael D Reed; Ravinder Anand; Karen Martz; Katherine Berezny; Daniel K Benjamin; P Brian Smith; Michael Cohen-Wolkowiez; Kevin Watt
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.938

6.  Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.

Authors:  Adriana Tremoulet; Jennifer Le; Brenda Poindexter; Janice E Sullivan; Matthew Laughon; Paula Delmore; Andrea Salgado; Sandy Ian-U Chong; Chiara Melloni; Jamie Gao; Daniel K Benjamin; Edmund V Capparelli; Michael Cohen-Wolkowiez
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.938

7.  A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data.

Authors:  Samantha H Dallefeld; Andrew M Atz; Ram Yogev; Janice E Sullivan; Amira Al-Uzri; Susan R Mendley; Matthew Laughon; Christoph P Hornik; Chiara Melloni; Barrie Harper; Andrew Lewandowski; Jeff Mitchell; Huali Wu; Thomas P Green; Michael Cohen-Wolkowiez
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-02-12       Impact factor: 2.410

Review 8.  Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children.

Authors:  Stephen J Balevic; Michael Cohen-Wolkowiez
Journal:  J Clin Pharmacol       Date:  2018-10       Impact factor: 2.860

9.  An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants.

Authors:  N Thakkar; D Gonzalez; M Cohen-Wolkowiez; M M Massaro; J Bernhardt; N R Zane; M M Laughon
Journal:  J Perinatol       Date:  2016-05-12       Impact factor: 3.225

10.  Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

Authors:  D Gonzalez; C Melloni; R Yogev; B B Poindexter; S R Mendley; P Delmore; J E Sullivan; J Autmizguine; A Lewandowski; B Harper; K M Watt; K C Lewis; E V Capparelli; D K Benjamin; M Cohen-Wolkowiez
Journal:  Clin Pharmacol Ther       Date:  2014-06-20       Impact factor: 6.903
  10 in total
  4 in total

1.  Population Pharmacokinetic Modeling of Total and Free Ceftriaxone in Critically Ill Children and Young Adults and Monte Carlo Simulations Support Twice Daily Dosing for Target Attainment.

Authors:  Sonya Tang Girdwood; Min Dong; Peter Tang; Erin Stoneman; Rhonda Jones; Toni Yunger; Austin Ostermeier; Calise Curry; Melissa Forton; Traci Hail; Randi Mullaney; Patrick Lahni; Nieko Punt; Jennifer Kaplan; Alexander A Vinks
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

2.  Molecular Adsorbent Recirculating System Therapy with Continuous Renal Replacement Therapy Enhanced Clearance of Piperacillin in a Pediatric Patient and Led to Failure to Attain Pharmacodynamic Targets.

Authors:  Sonya Tang Girdwood; Trent Arbough; Min Dong; Tomoyuki Mizuno; Peter Tang; Alexander A Vinks; Jennifer Kaplan
Journal:  Pharmacotherapy       Date:  2020-10-08       Impact factor: 4.705

3.  Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications.

Authors:  Ethan A Poweleit; Margaret A Cinibulk; Sarah A Novotny; Melissa Wagner-Schuman; Laura B Ramsey; Jeffrey R Strawn
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

4.  Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β-Lactam Antibiotics in Critically Ill Children.

Authors:  Sonya C Tang Girdwood; Peter H Tang; Mark E Murphy; Andrea R Chamberlain; Laura A Benken; Rhonda L Jones; Erin M Stoneman; Jennifer M Kaplan; Alexander A Vinks
Journal:  J Clin Pharmacol       Date:  2020-10-27       Impact factor: 3.126
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.